XERIS PHARMACEUTICALS INC

CUSIP: 98422LAA5 Class: Bond 30/360P2 U

Sessa Capital IM, L.P.'s Holding History (CIK: 0001595849)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023
Shares 13,975,000 Value ($000) $15,399 Avg Close — Range —
Q1 2023
Shares 12,975,000 Value ($000) $11,338 Avg Close — Range —
Q4 2022
Shares 9,975,000 Value ($000) $8,120 Avg Close — Range —
Q3 2022
Shares 9,975,000 Value ($000) $9,254 Avg Close — Range —
Q2 2022
Shares 9,975,000 Value ($000) $8,827 Avg Close — Range —
Q1 2022
Shares 9,975,000 Value ($000) $11,690 Avg Close — Range —
Q4 2021
Shares 9,975,000 Value ($000) $12,163 Avg Close — Range —
Q3 2021
Shares 9,975,000 Value ($000) $11,222 Avg Close — Range —
Q2 2021
Shares 9,975,000 Value ($000) $15,819 Avg Close — Range —
Q1 2021
Shares 9,200,000 Value ($000) $15,547 Avg Close — Range —
Q4 2020
Shares 7,450,000 Value ($000) $13,103 Avg Close — Range —
Q3 2020
Shares 7,450,000 Value ($000) $14,444 Avg Close — Range —